New drug timing may keep myeloma in check longer
NCT ID NCT00871013
First seen May 12, 2026 · Last updated May 16, 2026 · Updated 1 time
Summary
This study tests a different way of giving chemotherapy to people with multiple myeloma who have already received some treatment but not a transplant. The goal is to give lower doses of drugs in shorter cycles so that cancer cells have less time to grow back between treatments. Researchers hope this approach will lead to longer remissions and better survival for participants with high-risk myeloma.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
Conditions
Explore the condition pages connected to this study.